Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-23-105393

Options or other derivatives

  • Director acquired 26,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
GILL JOHN Director 2023-09-28 Grant or award · Stock Options (option to buy) +26,100 26,100 D: show line 1 in the form
Loading xslF345X05/tm2327241-4_4seq1.xml…